You accompany me to grow up I accompany you to the old
Release time:
2020-08-14
You accompany me to grow up
I accompany you to the old
Maybe you are really not outstanding or outstanding people, you don't know a few big characters, and you don't have any courage. What only dare to step by step, never dare to offend others.
Neighborhood folks all say that I am very much like you, but I don't want to be like you at all, because I hope I dare to gamble, dare to break, dare to fight, I hope my world is wonderful.
But this ending has been doomed since 28 years ago when I was born. My arrival has disrupted your original pace of life. You can only take care of me every day and work hard at home. However, he can only earn money tirelessly to support his family. Although you all work hard, wealth has always been out of touch with us.
I was 10 years old. In my memory, that was the first time you hit me. You asked me to deliver food to him who worked in the mountains, but I refused and quarreled with you. You slapped me on the ass and my foot hit the stone steps and became red. I cried and ran to find grandpa, who took me to send him the meal. Many years later, I heard grandma say that you hid at home and cried that day.
5 years ago, I left school, also far away from your vision, into the society. Although I don't often contact you, but you often call me, there are delicious food, weather changes, holidays, all have your care and greetings. Every time I ask you how you are, you always say that everything is fine at home. You always coughs over your phone, but how do you know how your calloused hand can cover the small microphone? I also know that his old problem may be committed again; I will not tell you that I was wronged at work, and sick again; I will only tell you that I am doing well, because then you will be relieved a lot. But you also know that I am a piece of meat that fell from you. Maybe I can only deceive each other tacitly.
As the saying goes, the love of the previous life is like the sea, so that the flesh and blood of this life can be repaired. We can't say "I love you", but I know we are all in each other's hearts. I can't participate in the first half of your life, and I will accompany you to the end for the rest of your life.
Dad, mom, you accompany me to grow up, I accompany you to grow old. (Sha Guowen)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31